Veröffentlicht: 03. Juli 2025 ; Gesehen am 13.11.2025
The benefits of physical activity are undisputed. However, adverse events can occur in rare cases, particularly during high-intensity or prolonged exercise. During physical activity, at-risk patients can experience major cardiac events, whereas adverse events affecting the musculoskeletal system are more common but less severe. A sports preparticipation evaluation (PPE) for apparently healthy adults is designed to detect at-risk individuals and prevent potentially fatal events. This guideline for conducting PPEs was developed by consensus among 16 medical societies and sports associations and is based on previously published guidelines and consensus papers. Sports medicine physicians and potential participants were also surveyed to assess the recommendations’ content, feasibility, and implementation. On the basis of the 20 recommendations developed and agreed upon by the abovementioned entities, PPE comprises individuals’ personal, family, and sports histories, as well as a physical examination. The need for additional examinations (e.g., laboratory parameters, echocardiograms, or stress tests) is determined on the basis of the PPE findings. This approach’s feasibility in various regions, including resource-limited settings, and the extent to which it prevents adverse or potentially fatal events, should be examined in future research.
Sports medicine Berlin [u.a.] : Springer, 1984 55(2025), 8, Seite 1827-1851 Online-Ressource
von Sophie Gottschalk ; Hans-Helmut König ; Tina Mallon ; Josefine Schulze ; Jan Weber ; Silke Böttcher ; Uta Sekanina ; Thomas Asendorf ; Eva Hummers ; Michael H. Freitag ; Nils Schneider ; Tim Friede ; Friedemann Nauck ; Martin Scherer ; Gabriella Marx ; Judith Dams
von Jutta Keller ; Thilo Wedel ; Holger Seidl ; Martin Ernst Kreis ; Ivo Raymond van der Voort ; Maximilian Gebhard ; Jost Langhorst ; Petra Lynen ; Oliver Schwandner ; Martin Storr ; Pia van Leeuwen ; Viola Andresen ; Jan Preiß ; Peter Layer ; Hans-Dieter Allescher ; Tilo Andus ; Stephan C. Bischoff ; Stephan Buderus ; M. Claßen ; U. Ehlert ; S. Elsenbruch ; M. Engel ; Axel Enninger ; Wolfgang Fischbach ; Michael H. Freitag ; Thomas Frieling ; Anton Gillessen ; M. Goebel-Stengel ; Juliane Dorothee Gschoßmann ; Felix Gundling ; S. Haag ; W. Häuser ; Ulf Helwig ; Stephan Hollerbach ; G. Holtmann ; M. Karaus ; M. Katschinski ; H. Krammer ; Wolfgang Kruis ; R. Kuhlbusch-Zicklam ; Ahmed Madisch ; H. Matthes ; Stephan Miehlke ; Hubert Mönnikes ; Stefan Müller-Lissner ; B. Niesler ; C. Pehl ; D. Pohl ; Carsten Posovszky ; M. Raithel ; Gabriele Röhrig-Herzog ; R. Schäfert ; M. Schemann ; Anjona Schmidt-Choudhury ; S. Schmiedel ; Anna Schweinlin ; Ilja Juliane Dorothee Schwille-Kiuntke ; A. Stengel ; Jonas Tesarz ; W. Voderholzer ; G. von Boyen ; J. von Schönfeld
von Alexander Häge ; Barbara Alm ; Tobias Banaschewski ; Katja Becker ; Michael Colla ; Christine Freitag ; Julia Geissler ; Alexander von Gontard ; Erika Graf ; Barbara Haack-Dees ; Susann Hänig ; Klaus Hennighausen ; Sarah Hohmann ; Christian Jacob ; Charlotte Jaite ; Christine Jennen-Steinmetz ; Viola Kappel ; Swantje Matthies ; Alexandra Philipsen ; Luise Poustka ; Wolfgang Retz ; Michael Rösler ; Katja Schneider-Momm ; Esther Sobanski ; Timo D. Vloet ; Andreas Warnke ; Thomas Jans
Multimodal treatment of children with ADHD often includes parent-child training (PCT). However, due to the high heritability, parents of children with ADHD are frequently also affected by the disorder, which is likely to constitute a significant barrier to successful treatment of the child. This secondary analysis of our randomized controlled multicentre AIMAC trial (ADHD in mothers and children) investigates whether children's outcomes following parent-child training in combination with maternal ADHD treatment depend on maternal symptom improvement. In a first step focusing on treatment of maternal ADHD, 144 mothers of mother-child dyads were randomized to multimodal ADHD treatment (group psychotherapy plus methylphenidate) or clinical management (mainly supportive counselling). After 12 weeks (T2), a 12-week PCT program (T2-T3) for all mother-child dyads was added to treat children's ADHD. Maternal symptomatology (CAARS-O:L; SCL-90-R) and children's externalizing symptoms (ADHD-ODD Scale, SDQ) were repeatedly assessed (T1 = baseline, T2, T3). Effects of changes in maternal symptomatology (T1-T2) on the change in children's symptom scores (T1-T3) were analysed using a general linear model, controlling for baseline scores, study centre, and maternal treatment group. 125 mother-child dyads were analysed. Mothers showed significant improvements in ADHD symptoms and overall psychopathology [CAARS-O:L ADHD index: mean - 3.54, SE 0.74 p < 0.0001; SCL-90-R Global Severity (GS): mean - 11.03, SE 3.90, p = 0.0056]. Although children's externalizing symptoms improved significantly (ADHD-ODD Scale: mean - 4.46, SE 0.58, p < 0.0001), maternal improvement had no effect on children's outcomes after Bonferroni-Holm correction for multiple testing. The findings do not support our hypothesis that children's outcomes following PCT for ADHD depend on maternal symptom improvements.Trial register CCT-ISRCTN73911400.
European child & adolescent psychiatry Darmstadt : Steinkopff, 1992 27(2018), 8, Seite 1011-1021 Online-Ressource
